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Introduction: Knowing total body volume (V) is crucial in patients on peritoneal dialysis
(PD).  It is usually calculated by the Watson anthropometric formula, although the use of
bioimpedance spectroscopy (BIS) is becoming increasingly widespread. Measuring V with
both  methods can at times produce quite different results.
Objective: We  aimed to identify differences between the 2 forms of measuring volume in a
PD  unit and determine which clinical factors are associated with these differences.
Methods: Ours is an observational study of 74 patients on PD. We  measured V using BIS
(Vbis) and the Watson formula (Vw); 271 measurements were made with each method. We
calculated the difference between Vbis and Vw in each patient and classiﬁed them into 2
groups: Difference between volumes ≥10% or <10% Vbis. We  assessed the presence of several
clinical parameters in our patients.
We  assessed whether there were any differences between Vbis and Vw (Student t-test).
We  determined whether there was any association between the difference in volumes and
the  presence of the clinical parameters analyzed (chi square test).
Results: V was 2.15 l higher measured by the Watson formula than with BIS (p < 0.01). In58.67% of the measurements, the difference between Vbis and Vw was ≥10%.
Signiﬁcant differences were found when comparing the presence of difference between
volumes and the presence or not of diabetes mellitus (DM) (p = 0.03), hypertension (HTN)
(p  = 0.036), hypoalbuminemia (p < 0.01), hypoprealbuminemia (p < 0.01), low phase angle at
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50 Hz (p < 0.01), high C reactive protein (p < 0.01), obesity (p = 0.027), E/I ratio (ratio between
extracellular and intracellular water) ≥1 (p < 0.01) and residual diuresis (p = 0.029).
Conclusions: There are signiﬁcant differences in the V of PD Unit patients when obtained by
Watson  formula or by BIS. A difference between the measurements is associated with the
presence of DM, HTN, hypoalbuminaemia, obesity, malnutrition, inﬂammation, E/I ratio ≥1
and  the absence of residual diuresis.
© 2015 Sociedad Espan˜ola de Nefrología. Published by Elsevier España, S.L.U. This is an
open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
Comparación  entre  bioimpedancia  espectroscópica  y  fórmula  de  Watson
para  medición  de  volumen  corporal  en  pacientes  en  diálisis  peritoneal
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Bioimpedancia espectroscópica
Fórmula de Watson
Volumen corporal total
r  e  s  u  m  e  n
Introducción: Conocer el volumen corporal total (V) es fundamental en los pacientes en diáli-
sis  peritoneal (DP). Habitualmente calculado mediante fórmula de Watson, el empleo de
bioimpedancia espectroscópica (BIS), cada vez está más generalizado. Frecuentemente, al
medir el V con ambos métodos surgen amplias diferencias.
Objetivo: Evaluar si aparecen diferencias entre ambas formas de medir el V en una unidad
de  DP y analizar qué factores clínicos se asocian a estas diferencias.
Métodos: Estudio observacional. Se incluyó a 74 pacientes en DP. Medimos el V empleando BIS
(Vbis) y fórmula de Watson (Vw); se recogieron 271 mediciones por cada método. Calculamos
diferencia entre volúmenes en cada medición y los clasiﬁcamos en 2 grupos: diferencia ≥10%
o  <10% de Vbis. Evaluamos la presencia de una serie de parámetros clínicos en nuestros
pacientes.
Analizamos si existen diferencias entre Vbis y Vw (de Student). Valoramos si existe aso-
ciación entre las diferencias entre volúmenes y la presencia de los parámetros clínicos
analizados (chi cuadrado).
Resultados: El Vbis fue 2,15 l mayor que Vw (p < 0,01). El 58,67% de las mediciones tenían
diferencia entre Vw y Vbis ≥10%. Aparecen diferencias signiﬁcativas al comparar la pres-
encia de diferencia entre volúmenes y la presencia o no de diabetes (p = 0,03), hipertensión
(p  = 0,036), hipoalbuminemia (p < 0,01), hipoprealbuminemia (p < 0,01), bajo ángulo de fase
a  50 Hz (p < 0,01), proteína C reactiva elevada (p < 0,01), obesidad (p = 0,027), exceso de grasa
corporal (p < 0,01), E/I ratio (cociente entre agua extracelular y agua intracelular)≥1 (p < 0,01)
y  diuresis residual (p = 0,029).
Conclusiones: Existen diferencias en el V de los pacientes de una unidad de DP según sea
calculado por fórmula de Watson o por BIS. La presencia de hipertensión, diabetes, hipoalbu-
minemia, obesidad, malnutrición, inﬂamación, E/I ratio ≥1 y la ausencia de diuresis residual
se  asocia con la aparición de estas diferencias.
©  2015 Sociedad Espan˜ola de Nefrología. Publicado por Elsevier España, S.L.U. Este es un
artículo Open Access bajo la licencia CC BY-NC-NDIntroduction
The measurement of total body volume (V) is a crucial param-
eter in patients on peritoneal dialysis (PD). First, it helps to
assess the patient’s hydration status, although what is more
relevant is he percentage of water relative to the total body
composition. However, the absolute value of V is used as the
denominator in the Kt/V equation; therefore, it is a key ele-
ment to know the dialysis efﬁciency.
The most common way to determine V in dialysis patients
is by anthropometric mathematical formulas, which are
simple and easily applicable. The most commonly used in
the general population, almost universally, is the Watson
formula.1(http://creativecommons.org/licenses/by-nc-nd/4.0/).
However, this equation has not been validated in patients
with different pathologies, particularly in dialysis patients.
The Watson formula uses patient’s sex, age, weight and height,
but it does not take into account the body composition nor the
distribution of water in patients on PD as compared to general
population.2–4
Recently, dialysis centers are using the bioimpedance spec-
troscopy (BIS) technique in both hemodialysis5,6 and PD7–10
patients. This technique uses a low intensity multifrequency
alternating current passing through the patient’s body to
determine a number of nutritional and hydration parameters,
including the V.11 BIS measurement is a simple, painless and
risk-free technique. Frequently, BIS measurements are replac-
ing the traditional anthropometric formulas as a method to
determine V in dialysis patients, or even both methods are
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while in 41.33% of the measurements, the difference was
<10%.
Comparison of risk factors or clinical features between
patients with or without difference in volumes revealed no
Table 1 – Risk factors present in analyzed patients.
Percentage (%)
HTA 87.8
Dyslipidemia 60.8
Diabetes mellitus 32.4
Vascular disease (ABI) 44.6
Ischemic heart disease 16.2
Ischemic neuropathy 10.8
Antiaggregant/OCP 44.6n e f r o l o g i a. 2
sed to calculate V. However, sometimes, in the same patient
he values of V obtained with these two methods are consid-
rably different which generates uncertainty about which of
he two V values should be accepted as valid.
The purpose of this study is, ﬁrst, to assess whether there
re differences in V measurements in PD patients using BIS
nd an anthropometric formula (Watson formula), and sec-
nd, to assess which factors may inﬂuence the occurrence of
hese differences.
atients  and  methods
e  conducted a prospective observational study involv-
ng 74 PD patients, 42 males (56.76%) and 32 females
43.24%) with an average age of 59, 98 ± 16, 96 (range
4.13 and 82.98 years). The causes of renal failure were
iabetic nephropathy (25.68%), followed by chronic tubuloin-
erstitial nephropathy (22.97%), chronic glomerulonephritis
18.92%), nephrosclerosis (12.16%), hepatorenal polycystic dis-
ase (6.76%) and ischemic nephropathy (2.70%), while the
tiology was unknown in 10.81%. Continuous ambulatory
eritoneal dialysis (CAPD) was used in 41 patients (55.41%),
hile automated peritoneal dialysis (APD) was used in 33
44.59%). According to the peritoneal transport as measured
y D/P creatinine, 47.97% were in the medium-low average
ransport, 47.60 in the medium-high, 2.58% in the high and
.85% in the low. The criteria to apply CAPD or APD was
he patient’s personal choice. Exclusion criteria for this study
ere the unability to perform the BIS test accurately: pres-
nce of major amputations and being a carrier of metal
omponents such as stents, pacemakers, prosthetic joints or
eﬁbrillators.
Values of height and weight were obtained in each
atient and a measurement of body volume by BIS (Body
omposition Monitor: Fresenius Medical Care) for total
ody volume (Vbis) was performed. Also a measurement
f hydration, extracellular water, intracellular water and
/I ratio was carried out. BIS was performed after fas-
ing, without diálisis12 solution in the abdomen and with
n empty bladder in those patients who maintained
esidual kidney function. The body volume was also cal-
ulated using the standard Watson equation (Vw) (men:
 = 2.447 − (0.09156 × age) + (0.1074 × height) + (0.3362×weight);
omen: V = (0.1096 × height) + (0.2466 × weight) − 2.097). Once
he volume was obtained by both methods, patients were
eparated into two groups according to the difference
btained using the two methods: ≥10% or <10% of Vbis
these percentages are above the standard error of V mea-
urements using BIS, which is estimated at 5%,). In total,
e have 271 volume measurements from the 74 patients
reviously described. The volumes are expressed as arith-
etic mean plus standard deviation. Student t test was
sed to analyze whether the difference between Vbis
nd Vw was signiﬁcant. In turn, we  performed a Bland
ltman test to evaluate the correlation between the 2
ethods.
In each patient, a number of features considered poten-
ially responsible for generating differences between volumes
ere recorded.3 6(1):57–62 59
- Personal parameters: age (≥65 or <65 years) and sex (male
or female).
- Clinical and pathological parameters: presence or absence
of hypertension (deﬁned as taking at least 2 antihyperten-
sive drugs), dyslipidemia, diabetes mellitus (DM), ischemic
heart disease, neuropathy, peripheral vascular disease mea-
sured by ankle-brachial index and the use of antiplatelets
aggregation agents or anticoagulants.
- Parameters associated with dialysis: type of PD (CAPD or
APD), peritoneal transport (D/P Cr ≥0.65 or <0.65) and pres-
ence of residual diuresis (deﬁned as greater than or equal to
400 cc/24 h).
- Nutritional and inﬂammatory parameters: E/I ratio mea-
sured by BIS (≥1 or <1), obesity (BMI ≥30 or <30 kg/m2), % of
body fat by BIS (≥25 or <25% in men  and 30% in women),
prealbumin (≥25 or <25 mg/dl), hypoalbuminemia (serum
albumin ≥3.5 or <3.5 g/dl), phase angle at 50 Hz (greater or
lower than average phase angle at 50 Hz obtained in all ana-
lyzed patients: 4.31◦) and CRP (≥5 or <5 mg/l).
Subsequently, we used the chi-square test to assess
whether there is an association between the differences in
volume and the presence or absence of the described clinical
parameters.
All statistical tests (Student t test, Bland Altman test and
chi square test) were performed by using SPSS 15.0 for Win-
dows, being p < 0.05 considered as signiﬁcant.
Results
We  assessed the presence or absence of a number of factors
and clinical parameters in patients and in the way mea-
surements were carried out. This information is shown in
Tables 1 and 2.
The average Vbis was 34.88 ± 7.81 l, while the average Vw
was 37.03 ± 6.3 l. The difference between the two  volumes was
2.15 l (p < 0.01) (Fig. 1). The agreement between VW and Vbis
values was signiﬁcant (r: −0.25, p < 0.01).
Parameters were separated according to the difference
between the 2 V values: ≥10% or <10%. The difference between
the two V values was ≥10%, in 58.67% of the measurementsGender (male) 56.8
Age ≥ 65 years 39.2
Type PD (CAPD) 55.4
60  n e f r o l o g i a. 2 0 1 
Table 2 – Risk factors present in the measurements.
Percentage (%)
Hypoalbuminemia (<3.5 g/l) 62
Prealbumin <25 mg/dl 32.1
Phase angle (50 Hz) <4.3◦ 52
E/I (>1) 32.8
Obesity (BMI ≥ 30 kg/m2) 29.9
Body fat ≥25%/30% in male/female 67.2
Elevated CRP (>5 mg/l) 60.5
Peritoneal transport (D/P Cr ≥0.65) 50.2
Overhydration (OH > 1.1 L) 59
Residual diuresis (>400 cc/24 h) 58.7
0
5
10
15
20
25
30
35
40
VwVbis
Li
tre
sFig. 1 – Volume (l) calculated with the Watson formula (Vw)
and BIS (Vbis) (p < 0.01).signiﬁcant difference in dyslipidemia (p = 0.63), peripheral
vascular disease (p = 0.63), ischemic heart disease (p = 0.96),
ischemic neuropathy (0.93), antiaggregant/OCP (p = 0.92), gen-
der (p = 0.69), age (p = 0.18), peritoneal transport type (p = 0.09)
Table 3 – Comparison of clinical, pathological and personal par
Analyzed parameter parameter% in a group with
difference between V > 10%
HTA 90.2 
Dyslipidemia 64.7 
Diabetes mellitus 42.5 
Vascular disease (ABI) 52.9 
Ischemic heart disease 16.3 
Ischemic neuropathy 10.5 
Antiaggregant/anticoagulation 50.9 
Gender (male) 59.5 
Age (over 65) 49.7  
Table 4 – Comparison of nutritional and inﬂammatory paramete
Analyzed parameter parameter% in group w
difference between V >
Type of PD (CAPD) 56.9 
Peritoneal transport (PD/Cr ≥ 0.65) 45.1 
Residual diuresis (≥400 cc) 52.9 
Serum albumin (<3.5 g/l) 81.7 
Prealbumin (<25 mg/dl) 52.9 
Phase angle at 50 Hz (≥4.31◦) 62.1 
E/I (≥1) 59.5 
Obesity (BMI ≥ 30 kg/m2) 35.3 
% of body fat (≥25% male or ≥30% female) 77.1 
PCR (≥5 mg/dl) 81 6;3  6(1):57–62
and type of PD (p = 0.79). However, signiﬁcant differences were
found in the presence of hypertension (p < 0.05), DM (p < 0.05),
hypoalbuminemia (p < 0.01), hypoprealbuminemia (p < 0.01),
obesity (BMI) (p < 0.05), excess of body fat (p < 0.01), inﬂamma-
tion as measured by C reactive protein (CRP) (p < 0.01), E/I high
(p < 0.01) decreased phase angle at 50 Hz (p < 0.01) and residual
diuresis (p < 0.05) (Tables 3 and 4).
Discussion
Determination the V with the highest possible accuracy in PD
patients is essential. Besides being necessary to determine
the dialysis efﬁciency (Kt/V13 equation), excess of volume
is associated with inﬂammation,14 malnutrition,15 hyperten-
sion, ventricular hypertrophy,16,17 acardiovascular events18,19
and other pathological processes.20 Therefore, ﬁnding the
most objective way of measuring this volume in our patients
is essential.
Techniques commonly accepted as gold standard, such
as deuterium dilution techniques are costly, complex or
painful, and thus have limited applicability in everyday clinical
practice. Measuring V with the Watson formula is seen as an
easy and applicable method, this is why this method for calcu-
lating the body volume is widespread in dialysis centers.19,20
The avenue of BIS during the recent years has changed the
method to assess hydration status in dialysis patients. BIS’s
theoretical advantage is that directly measure V and thus
eliminates the error that may occur in anthropometric for-
mula, to the point that it has been compared in several studies
to gold standard methods in the measurement of V.20,21 It
also provides important information about the patients’ dis-
tribution of body water and nutritional status. Therefore, at
ameters and V differences (Chi square).
parameter% in a group with
difference between V < 10%
Chi  square (p)
81.4 0.036
61.9 0.63
29.7 0.03
50 0.63
16.1 0.96
10.2 0.93
40.7 0.92
61.9 0.69
41.5 0.18
rs associated with dialysis and V differences (Chi square).
ith
 10%
parameter% in group with
difference between V < 10%
Chi  square (p)
58.5 0.79
71.2 0.09
66.1 0.029
38.4 <0.01
5.1 <0.01
49.2 <0.01
33.9 <0.01
22.9 0.027
53.4 <0.01
33.9 <0.01
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resent, both ways of measuring V can be regarded as appro-
riate in clinical practice.
The problem arises when both methods (Vbis and Vw) lead
o considerable differences. Measuring the volume with the
atson formula should be simple, and results are applicable,
t least, to the general population. However, PD patients have,
y deﬁnition a different distribution of body water as com-
ared to the general population and, in turn, they often have
 number of clinical and pathological conditions that may con-
ribute to the different distribution of V. These patients may
eneﬁt from measuring V with BIS and not with the Watson
ormula, which takes into account gender, age, weight and
eight, but is not inﬂuenced by the complex combination of
actors present in PD patients.
In the study conducted in our PD unit, ﬁrst we observed, as
n other studies, that the Watson formula overestimates V as
ompared with BIS22,23 measurement. We  also found signiﬁ-
ant differences in some of the features of patients according
o whether they had differences in V: hypertension, diabetes,
esidual diuresis, obesity (due to BMI  and % of body fat), serum
lbumin/prealbuminemia, PCR, phase angle at 50 Hz and E/I.
peciﬁcally, the difference between Vbis and Vw was greater
han 10% in hypertensive, diabetic, obese (BMI ≥ 30 kg/m2 and
ody fat percentage ≥25% in men  and 30% women), mal-
ourished (albumin <3.5 g/dl, prealbumin <25 mg/dl and phase
ngle at 50 Hz below average), swollen (PCR >5 mg/l) patients
nd in patients without residual diuresis and E/I ratio greater
han one, signiﬁcantly.
While assessing the reason why these patients show a
ifference between Vbis and Vw, it became evident that partic-
larly diabetic24,25 patients, had a tendency for inﬂammation
hich causes a different distribution of body volume.
The same can be applied to malnourished patients.
nterestingly, regardless of the method used for evalua-
ion, either prealbumin, or albumin (as nutritional marker,
part from morbidity and mortality marker) or the increas-
ngly used phase angle at 50 Hz for BIS26,27 in all cases the
resence of poor nutrition generates differences between
he two methods of assessing V. This is probably related
o inﬂammation and the different distribution of body
ater.
Something similar occurs in obese patients: excess of body
ass due mainly to fat, but also to lean mass and, the ten-
ency to ﬂuid overload may interfere with the use of the
ormula for the calculation of V.28,29
The excess of volume, or the abnormal distribution in the
ody, is another factor causing the difference between Vbis
nd Vw. Considering residual diuresis, patients that maintain
iuresis once initiated into the technique have better con-
rol ﬂuids, which is beneﬁcial. And patients with lees diuresis
end to be malnourished.30 Therefore, it is not surprising that
arge differences between the two ways of measuring V arise
n patients who  have no diuresis, and worse management of
ody water.
Something similar may occur in cases of hypoalbumine-
ia. It is well known that the loss of oncotic pressure causedy reduced serum proteins generates a redistribution of the
ntravascular volume with a tendency to edema and forma-
ion of “third space”. This is not accounted for by Watson
ormula,31 which only takes into account the weight, age,3 6(1):57–62 61
height and sex, but does not consider16 nutritional status or
inﬂammation.
The same happens with the high E/I ratio. A result >1 may
be caused either by an excess of extracellular water, and there-
fore hyperhydration and edema, or by a lack of intracellular
water, and thus low “total cell mass” and malnutrition or even
the association of both.32 In any case, the conclusion would be
the same: different distribution of body volume and, therefore,
a likely beneﬁt from a direct measurement of V.
We do not know whether in the general population dif-
ferences in V would we seen and whether the previously
described factors (hypertension, diabetes mellitus, hypoalbu-
minemia, hipoprealbuminemia, high CRP, obesity, decreased
phase angle at 50 Hz and high E/I), are applicable. In addition,
it is unknown whether performing PD, is a necessary factor for
these differences to appear.
In conclusion, an accurate determination of V in PD
patients is essential and therefore it is important to ﬁnd the
most appropriate method to measure it considering clini-
cal and pathological conditions. According to our results, PD
patients with hypertension, diabetics, without residual diure-
sis, obese, swollen and malnourished may beneﬁt from the
determination of V using BIS. The results presented here
should be conﬁrmed with studies using greater number of
patients.
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